FDA Announces Nationwide Recall of Cholesterol Medication – More Than 140,000 Bottles Affected

Published On:
FDA Announces Nationwide Recall of Cholesterol Medication - More Than 140,000 Bottles Affected

Over 140,000 bottles of a prescription statin have been recalled due to “failed dissolution specifications,” according to a U.S. Food and Drug Administration (FDA) enforcement report.

Ascend Laboratories of New Jersey pulled Atorvastatin Calcium, a drug sold as a generic version of Lipitor, that were manufactured by Alkem Laboratories of India and distributed nationwide. The recall, issued on Sept. 19, covers tablets packaged in 90-count, 500-count and 1,000-count bottles with expiration dates as late as February 2027.

On Oct. 10, the FDA classified the recalled prescription medication as a Class II recall. The risk classification from the federal agency indicates that the recalled medications could cause “temporary or medically reversible adverse health consequences,” but that the chances of serious adverse health consequences are “remote.

If you or someone in your family takes medication for cholesterol, especially atorvastatin, it’s important to know the details of this recall and understand what steps to take next.

What Medicine Has Been Recalled?

The recall is for atorvastatin calcium tablets, a common medicine used to lower high cholesterol levels and reduce the risk of heart disease. This is the generic version of the well-known brand Lipitor. The company behind this recall is Ascend Laboratories, and it affects multiple dosage strengths.

Key Details of the Recalled Tablets

Here’s a quick summary of the affected products:

BrandDosage StrengthsPack SizeType of Recall
Ascend Laboratories10 mg, 20 mg, 40 mg, 80 mg90-count bottlesClass II

This recall has been issued because the tablets may not dissolve properly in the body. If a tablet doesn’t dissolve the way it should, the medicine might not work as expected. This can lead to cholesterol levels staying high, which may affect your heart health in the long run.

What statin prescription bottles are under the recall?

The recall covers the following products:

Product DescriptionPill countLot number
Atorvastatin Calcium Tablets USP, 10 mg90-count bottle (NDC 67877-511-90)Lot#: 25141249, Exp. Feb. 2027 Lot#: 24144938, Exp. Nov. 2026Lot#: 24144868, Exp. Nov. 2026 Lot#: 24144867, Exp. Nov. 2026 Lot#: 24144458, Exp. Sep. 2026 Lot#: 24143994, Exp. Sep. 2026 Lot#: 24142987, Exp. July 2026 Lot#: 24143316, Exp. July 2026
Atorvastatin Calcium Tablets USP, 10 mg500-count bottle (NDC 67877-511-05)Lot#: 25141249, Exp. Feb. 2027 Lot#: 24144938, Exp. Nov. 2026Lot#: 24144868, Exp. Nov. 2026 Lot#: 24144867, Exp. Nov. 2026 Lot#: 24144458, Exp. Sep. 2026 Lot#: 24143994, Exp. Sep. 2026 Lot#: 24142987, Exp. July 2026 Lot#: 24143316, Exp. July 2026
Atorvastatin Calcium Tablets USP, 10 mg1000-count bottle (NDC 67877-511-10)Lot#: 25141249, Exp. Feb. 2027 Lot#: 24144938, Exp. Nov. 2026Lot#: 24144868, Exp. Nov. 2026 Lot#: 24144867, Exp. Nov. 2026 Lot#: 24144458, Exp. Sep. 2026 Lot#: 24143994, Exp. Sep. 2026 Lot#: 24142987, Exp. July 2026 Lot#: 24143316, Exp. July 2026
Atorvastatin Calcium Tablets USP, 40 mg, Rx Only90-count (NDC 67877-513-90)Lot#: 25140933, Exp. Feb. 2027 Lot#: 25140477, Exp. Dec. 2026 Lot#: 24144254, Exp. Oct. 2026 Lot#: 24144163, Exp. Sep. 2026 Lot#: 24143995, Exp. Sep. 2026
Atorvastatin Calcium Tablets USP, 40 mg, Rx Only500-count (NDC 67877-513-05)Lot#: 25140933, Exp. Feb. 2027 Lot#: 25140477, Exp. Dec. 2026 Lot#: 24144254, Exp. Oct. 2026 Lot#: 24144163, Exp. Sep. 2026 Lot#: 24143995, Exp. Sep. 2026
Atorvastatin Calcium Tablets USP, 40 mg, Rx Only1000-count (NDC 67877-513-10)Lot#: 25140933, Exp. Feb. 2027 Lot#: 25140477, Exp. Dec. 2026 Lot#: 24144254, Exp. Oct. 2026 Lot#: 24144163, Exp. Sep. 2026 Lot#: 24143995, Exp. Sep. 2026
Atorvastatin Calcium Tablets USP, 20 mg, Rx Only90-count(NDC 67877-512-90)Lot #: 25140150, Exp. Dec. 2026 Lot #: 25140173, Exp. Dec. 2026 Lot #: 25140172, Exp. Dec. 2026 Lot #: 24144720, Exp. Nov. 2026 Lot #: 24144798, Exp. Nov. 2026 Lot #: 24144692, Exp. Oct. 2026 Lot #: 24143755, Exp. Aug. 2026 Lot #: 24143913, Exp. Aug. 2026 Lot #: 24143754, Exp. Aug. 2026 Lot #: 24143047, Exp. June 2026 Lot #: 24142936, Exp. July 2026
Atorvastatin Calcium Tablets USP, 20 mg, Rx Only500-count (NDC 67877-512-05)Lot #: 25140150, Exp. Dec. 2026 Lot #: 25140173, Exp. Dec. 2026 Lot #: 25140172, Exp. Dec. 2026 Lot #: 24144720, Exp. Nov. 2026 Lot #: 24144798, Exp. Nov. 2026 Lot #: 24144692, Exp. Oct. 2026 Lot #: 24143755, Exp. Aug. 2026 Lot #: 24143913, Exp. Aug. 2026 Lot #: 24143754, Exp. Aug. 2026 Lot #: 24143047, Exp. June 2026 Lot #: 24142936, Exp. July 2026
Atorvastatin Calcium Tablets USP, 20 mg, Rx Only1000-count(NDC 67877-512-10)Lot #: 25140150, Exp. Dec. 2026 Lot #: 25140173, Exp. Dec. 2026 Lot #: 25140172, Exp. Dec. 2026 Lot #: 24144720, Exp. Nov. 2026 Lot #: 24144798, Exp. Nov. 2026 Lot #: 24144692, Exp. Oct. 2026 Lot #: 24143755, Exp. Aug. 2026 Lot #: 24143913, Exp. Aug. 2026 Lot #: 24143754, Exp. Aug. 2026 Lot #: 24143047, Exp. June 2026 Lot #: 24142936, Exp. July 2026
Atorvastatin Calcium Tablets USP, 80 mg, Rx Only90-count(NDC 67877-514-90)Lot#: 25140249, Exp. Dec. 2026 Lot#: 25140247, Exp. Dec. 2026 Lot#: 24144999, Exp. Nov. 2026 Lot#: 24144942, Exp. Nov. 2026 Lot#: 24144845, Exp. Nov. 2026 Lot#: 24144713, Exp. Nov. 2026 Lot#: 24144652, Exp. Oct. 2026 Lot#: 24143898, Exp. Aug. 2026 Lot#: 24143412, Exp. Aug. 2026 Lot#: 24143582, Exp. Aug. 2026
Atorvastatin Calcium Tablets USP, 80 mg, Rx Only500-count(NDC 67877-514-05)Lot#: 25140249, Exp. Dec. 2026 Lot#: 25140247, Exp. Dec. 2026 Lot#: 24144999, Exp. Nov. 2026 Lot#: 24144942, Exp. Nov. 2026 Lot#: 24144845, Exp. Nov. 2026 Lot#: 24144713, Exp. Nov. 2026 Lot#: 24144652, Exp. Oct. 2026 Lot#: 24143898, Exp. Aug. 2026 Lot#: 24143412, Exp. Aug. 2026 Lot#: 24143582, Exp. Aug. 2026

What Is a Class II Recall?

In simple words, a Class II recall means the issue is not likely to cause serious harm, but the product could still cause temporary health problems or fail to give the expected results. It’s not an emergency, but you should still take it seriously.

Why This Matters for Your Health

Atorvastatin works by reducing bad cholesterol (LDL) and increasing good cholesterol (HDL). If the tablet doesn’t break down properly in your stomach, the medicine may not get absorbed well into your body. This could result in:

  • No significant change in cholesterol levels
  • Risk of heart problems not reducing as expected
  • Unusual tiredness or mild chest discomfort (in rare cases)

Even if these effects aren’t life-threatening, they can affect your treatment progress.

What You Should Do If You Have This Medicine

If you are using atorvastatin calcium tablets from Ascend Laboratories, follow these steps:

  • Check the bottle label for the brand, dosage (10, 20, 40 or 80 mg), and pack size (90 tablets).
  • Do not stop taking the medicine suddenly. Talk to your doctor or pharmacist first.
  • If your tablets are part of the recall, your pharmacist might give you a replacement from a different batch or brand.
  • Inform your doctor if you feel the medicine is not working or if you notice unusual symptoms.

How to Know If Your Medicine Isn’t Working Well

Some signs that your cholesterol medicine may not be effective include:

  • No improvement in cholesterol levels after regular tests
  • Feeling more tired than usual
  • Mild chest discomfort (though rare)

If you feel something’s not right, don’t wait—talk to your doctor.

Is This Recall Serious?

The recall is mostly a preventive step, taken to ensure patient safety. There are no reports of anyone falling sick due to this issue so far. But this incident shows how important it is for medicines to not just have the right ingredients, but also work properly once inside the body.

This recall reminds us that even widely used medicines can have quality issues, and staying alert helps protect your health. Always check your medicine labels and reach out to a doctor if you’re unsure about any changes or issues.

Medicine safety isn’t just about what’s in the pill—it’s also about how that pill behaves once it’s inside your body. The atorvastatin calcium tablet recall by Ascend Laboratories is a good reminder to stay alert and proactive when it comes to your health.

If you or someone in your family takes cholesterol medicine, double-check the label, speak to your doctor, and make sure your treatment stays on track. Even though the risk is low, taking timely action can prevent bigger health problems later.

Source

FAQ:

Q1. Which atorvastatin tablets are being recalled?
The recall includes 10 mg, 20 mg, 40 mg, and 80 mg atorvastatin calcium tablets from Ascend Laboratories in 90-count bottles.

Q2. Why were the tablets recalled?
They may not dissolve properly in the body, reducing the medicine’s effectiveness in lowering cholesterol.

Q3. Is it safe to continue taking the recalled medicine?
Don’t stop the medicine on your own. Contact your doctor or pharmacist to check if your tablets are affected and to get a replacement if needed.

Q4. What are the risks if the tablet doesn’t dissolve properly?
Your cholesterol levels may not come down as expected, and the risk of heart problems may not reduce. However, the issue is not considered life-threatening.

Q5. What is a Class II recall?
A Class II recall means the product could cause temporary or medically reversible health problems, but the risk of serious harm is low.

Isabella

Isabella is a dedicated education strategist at The Academic Network, Inc., passionate about helping schools and universities achieve excellence through innovation and collaboration. With a focus on strategic growth, leadership development, and student success, Isabella empowers institutions to adapt, thrive, and build sustainable futures in an ever-evolving educational landscape.

1 thought on “FDA Announces Nationwide Recall of Cholesterol Medication – More Than 140,000 Bottles Affected”

  1. Why can’t can’t these companies do pre checking tests before entering their products into market so that companies may get benefit from all these recall issues and also get financial benefit and trust will not be lost from the market. Instead of recalling the products from the market the govt and the companies should have been tested for each batch before entering into markets. Ultimately the patients as well as the companies, will get benefit from health and financial,trust,respectively.

    Reply

Leave a Comment